Congratulations to A/Prof Colm Keane and the BrainCAR19 study
News, Newsletter May 13, 2024
Congratulations to A/Prof Colm Keane for his successful grant for the BrainCAR19 trial as announced by the Minister for Health and…
Our manuscript is highlighted by the limbic
News, Newsletter May 3, 2024
We are very delighted to have our polatuzumab manuscript displayed in the news story in the limbic. The registry is a collaborative effort…
April 2024 newsletter is here.
News, Newsletter April 3, 2024
Click here to read our April newsletter. Leave us a message if you would like to join the subscription list for future…
2024 Blood abstract submission opens
News, Newsletter March 27, 2024
Abstract submission to Blood 2024 is now open until 29 May 2024. More information about Blood: https://www.blood2024.com/ Let us know if…
GLOW consortium utilised LaRDR data in a prognostic model
News, Newsletter March 27, 2024
Congratulations to Dr Michael Binkley and other investigators who utilised LaRDR data in the International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin…
Early view of the GELF criteria study published on Haematologica
News, Newsletter March 26, 2024
Congratulations to Dr Allison Barraclough, and other investigators who published an early view version of the Impact and utility of…
7500th patient recruitment
News, Newsletter March 16, 2024
Congratulations to all participating sites at the Lymphoma and Related Diseases Registry (LaRDR) for enrolling the 7500th patient on March 14, 2024. We would like…
LaRDR supports Rare Disease Day 2024
News, Newsletter February 28, 2024
We acknowledge the research participation and support provided by patients, carers and their clinicians. We continue to provide a national…
Polatuzumab manuscript published on ejHaem
News, Newsletter February 26, 2024
Congratulations to Dr Briony Shaw, Ms Eliza Chung and other investigators who utilised LaRDR data to analyse outcomes of relapsed/ refractory…
7000th patient recruitment
News, Newsletter January 17, 2024
Congratulations to all participating sites at the Lymphoma and Related Diseases Registry (LaRDR) for enrolling the 7000th patient on January 4, 2024. We would like…